Bjorn Knollmann Archives
Jan. 14, 2016—Björn Knollmann, M.D., Ph.D., has been named director of the newly formed Vanderbilt Center for Arrhythmia Research and Therapeutics (VanCART).
Jan. 14, 2016—A team of Vanderbilt investigators developed a new method for rapidly generating heart muscle cells from stem cells.
May. 12, 2014—A particular anti-arrhythmia drug provides a targeted treatment for certain forms of atrial fibrillation.